227 related articles for article (PubMed ID: 11504808)
1. Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5.
Perchenet L; Hilfiger L; Mizrahi J; Clément-Chomienne O
J Pharmacol Exp Ther; 2001 Sep; 298(3):1108-19. PubMed ID: 11504808
[TBL] [Abstract][Full Text] [Related]
2. Characterization of mibefradil block of the human heart delayed rectifier hKv1.5.
Perchenet L; Clément-Chomienne O
J Pharmacol Exp Ther; 2000 Nov; 295(2):771-8. PubMed ID: 11046117
[TBL] [Abstract][Full Text] [Related]
3. Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.
Kim SE; Ahn HS; Choi BH; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
J Pharmacol Exp Ther; 2007 May; 321(2):753-62. PubMed ID: 17312186
[TBL] [Abstract][Full Text] [Related]
4. Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations.
Caballero R; Gómez R; Núñez L; Moreno I; Tamargo J; Delpón E
Cardiovasc Res; 2004 Dec; 64(3):457-66. PubMed ID: 15537499
[TBL] [Abstract][Full Text] [Related]
5. State-dependent block of rabbit vascular smooth muscle delayed rectifier and Kv1.5 channels by inhibitors of cytochrome P450-dependent enzymes.
Iftinca M; Waldron GJ; Triggle CR; Cole WC
J Pharmacol Exp Ther; 2001 Aug; 298(2):718-28. PubMed ID: 11454936
[TBL] [Abstract][Full Text] [Related]
6. Cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate and nordihydroguaiaretic acid inhibit human Kv1.5 currents independently of lipoxygenase.
Gong YZ; Ding WG; Wu J; Tsuji K; Horie M; Matsuura H
Eur J Pharmacol; 2008 Dec; 600(1-3):18-25. PubMed ID: 18930721
[TBL] [Abstract][Full Text] [Related]
7. Papaverine blocks hKv1.5 channel current and human atrial ultrarapid delayed rectifier K+ currents.
Choe H; Lee YK; Lee YT; Choe H; Ko SH; Joo CU; Kim MH; Kim GS; Eun JS; Kim JH; Chae SW; Kwak YG
J Pharmacol Exp Ther; 2003 Feb; 304(2):706-12. PubMed ID: 12538825
[TBL] [Abstract][Full Text] [Related]
8. Effect of descarboethoxyloratadine, the major metabolite of loratadine, on the human cardiac potassium channel Kv1.5.
Caballero R; Delpón E; Valenzuela C; Longobardo M; Franqueza L; Tamargo J
Br J Pharmacol; 1997 Nov; 122(5):796-8. PubMed ID: 9384491
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes.
Bachmann A; Gutcher I; Kopp K; Brendel J; Bosch RF; Busch AE; Gögelein H
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):472-8. PubMed ID: 11692231
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective interactions of the enantiomers of chromanol 293B with human voltage-gated potassium channels.
Yang IC; Scherz MW; Bahinski A; Bennett PB; Murray KT
J Pharmacol Exp Ther; 2000 Sep; 294(3):955-62. PubMed ID: 10945846
[TBL] [Abstract][Full Text] [Related]
11. Voltage- and time-dependent block by perhexiline of K+ currents in human atrium and in cells expressing a Kv1.5-type cloned channel.
Rampe D; Wang Z; Fermini B; Wible B; Dage RC; Nattel S
J Pharmacol Exp Ther; 1995 Jul; 274(1):444-9. PubMed ID: 7616429
[TBL] [Abstract][Full Text] [Related]
12. Modulation of a cloned human A-type voltage-gated potassium channel (hKv1.4) by the protein tyrosine kinase inhibitor genistein.
Zhang ZH; Wang Q
Pflugers Arch; 2000 Sep; 440(5):784-92. PubMed ID: 11007322
[TBL] [Abstract][Full Text] [Related]
13. Characterization of human cardiac Kv1.5 inhibition by the novel atrial-selective antiarrhythmic compound AVE1231.
Ehrlich JR; Ocholla H; Ziemek D; Rütten H; Hohnloser SH; Gögelein H
J Cardiovasc Pharmacol; 2008 Apr; 51(4):380-7. PubMed ID: 18427281
[TBL] [Abstract][Full Text] [Related]
14. The membrane permeable calcium chelator BAPTA-AM directly blocks human ether a-go-go-related gene potassium channels stably expressed in HEK 293 cells.
Tang Q; Jin MW; Xiang JZ; Dong MQ; Sun HY; Lau CP; Li GR
Biochem Pharmacol; 2007 Dec; 74(11):1596-607. PubMed ID: 17826747
[TBL] [Abstract][Full Text] [Related]
15. Effect of lanthanum on voltage-dependent gating of a cloned mammalian neuronal potassium channel.
Tytgat J; Daenens P
Brain Res; 1997 Feb; 749(2):232-7. PubMed ID: 9138723
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hypertensive factor inhibits voltage-gated K+ channels in vascular smooth muscle cells.
Ren J; Zhang L; Benishin CG
Can J Physiol Pharmacol; 1999 Nov; 77(11):860-5. PubMed ID: 10593658
[TBL] [Abstract][Full Text] [Related]
17. Modulation of voltage sensitivity by N-terminal cytoplasmic residues in human Kv1.2 channels.
Varshney A; S K; Mathew MK
Eur Biophys J; 2002 Sep; 31(5):365-72. PubMed ID: 12202912
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of action of antiarrhythmic agent bertosamil on hKv1.5 channels and outward potassium current in human atrial myocytes.
Godreau D; Vranckx R; Hatem SN
J Pharmacol Exp Ther; 2002 Feb; 300(2):612-20. PubMed ID: 11805224
[TBL] [Abstract][Full Text] [Related]
19. HMJ-53A accelerates slow inactivation gating of voltage-gated K+ channels in mouse neuroblastoma N2A cells.
Chao CC; Shieh J; Kuo SC; Wu BT; Hour MJ; Leung YM
Neuropharmacology; 2008 Jun; 54(7):1128-35. PubMed ID: 18406431
[TBL] [Abstract][Full Text] [Related]
20. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current.
Lagrutta A; Wang J; Fermini B; Salata JJ
J Pharmacol Exp Ther; 2006 Jun; 317(3):1054-63. PubMed ID: 16522807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]